Literature DB >> 20975339

Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type.

Robert Nakayama1, Sachiyo Mitani, Takeshi Nakagawa, Tadashi Hasegawa, Akira Kawai, Hideo Morioka, Hiroo Yabe, Yoshiaki Toyama, Akira Ogose, Junya Toguchida, Tomitaka Nakayama, Teruhiko Yoshida, Hitoshi Ichikawa.   

Abstract

Poorly differentiated type synovial sarcoma (PDSS) is a variant of synovial sarcoma characterized by predominantly round or short-spindled cell morphology. Although accumulating evidence from clinicopathologic studies suggests a strong association between this variant of synovial sarcoma and poor prognosis, little has been reported on the molecular basis of PDSS. To gain insights into the mechanism(s) that underlie the emergence of PDSS, we analyzed the gene expression profiles of 34 synovial sarcoma clinical samples, including 5 cases of PDSS, using an oligonucleotide microarray. In an unsupervised analysis, the 34 samples fell into 3 groups that correlate closely with histologic subtypes: monophasic, biphasic, and poorly differentiated types. PDSS was characterized by down-regulation of genes associated with neuronal and skeletal development and cell adhesion. Moreover, upregulation of genes on a specific chromosomal locus, 8q21.11, was identified. This locus-specific transcriptional activation in PDSS was confirmed by reverse transcriptase-PCR analysis of 9 additional synovial sarcoma samples. Our results indicate that PDSS tumors constitute a distinct group based on expression profiles.

Entities:  

Mesh:

Year:  2010        PMID: 20975339     DOI: 10.1097/PAS.0b013e3181f7ce2c

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  [Sarcomas: classification with morphologic and genetic criteria].

Authors:  H-U Schildhaus; R Büttner
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

Review 2.  Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas.

Authors:  Anish Ray; Winston W Huh
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

3.  Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.

Authors:  Le Su; Arthur V Sampaio; Kevin B Jones; Marina Pacheco; Angela Goytain; Shujun Lin; Neal Poulin; Lin Yi; Fabio M Rossi; Juergen Kast; Mario R Capecchi; T Michael Underhill; Torsten O Nielsen
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.

Authors:  Yu-Chien Kao; Adepitan A Owosho; Yun-Shao Sung; Lei Zhang; Yumi Fujisawa; Jen-Chieh Lee; Leonard Wexler; Pedram Argani; David Swanson; Brendan C Dickson; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

Review 5.  Proteomic analysis of soft tissue sarcoma.

Authors:  Yoshiyuki Suehara
Journal:  Int J Clin Oncol       Date:  2011-03-09       Impact factor: 3.402

Review 6.  Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.

Authors:  Torsten O Nielsen; Neal M Poulin; Marc Ladanyi
Journal:  Cancer Discov       Date:  2015-01-22       Impact factor: 39.397

7.  BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Achim A Jungbluth; Shih-Chiang Huang; Pedram Argani; Narasimhan P Agaram; Angelica Zin; Rita Alaggio; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

8.  Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors.

Authors:  Miwa Tanaka; Yukari Yamazaki; Yohei Kanno; Katsuhide Igarashi; Ken-ichi Aisaki; Jun Kanno; Takuro Nakamura
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

9.  SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas.

Authors:  K B Jones; L Su; H Jin; C Lenz; R L Randall; T M Underhill; T O Nielsen; S Sharma; M R Capecchi
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

10.  Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).

Authors:  Yi-Che Changchien; Péter Tátrai; Gergő Papp; Johanna Sápi; László Fónyad; Miklós Szendrői; Zsuzsanna Pápai; Zoltán Sápi
Journal:  J Transl Med       Date:  2012-10-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.